PRESS RELEASE published on 06/03/2026 at 07:30, 27 days 18 hours ago Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 24, 2026 and appointment of an ad hoc representative Nicox SA announces Ordinary and Extraordinary Shareholders' Meeting on June 24, 2026, with appointment of ad hoc representative. Details and resolutions included Shareholders' Meeting General Meeting Ophthalmology Nicox Ad Hoc Representative
BRIEF published on 04/20/2026 at 07:35, 2 months 10 days ago Last day for exercising Nicox warrants: June 19, 2026 Euronext Growth Deadline Share Subscription Ophthalmology BSA Nicox
BRIEF published on 04/20/2026 at 07:35, 2 months 10 days ago Nicox Sets Deadline for June 2024 Warrants Exercise Warrants Shares Euronext Nicox Exercise Deadline
PRESS RELEASE published on 04/20/2026 at 07:30, 2 months 10 days ago Reminder: Last Exercise Day for Nicox June 2024 Warrants is June 19, 2026 Nicox SA reminds warrant holders of the upcoming expiration date on June 19, 2026. The warrants, with ISIN code FR001400QEQ3, provide the right to subscribe to new shares at €0.275 per share Euronext Growth Paris Warrants Equity Offering Expiration Date Nicox SA
BRIEF published on 02/24/2026 at 07:35, 4 months 4 days ago Nicox Reveals Positive Phase 3 Results for NCX 470 at AGS Meeting Glaucoma Phase 3 Study NCX 470 Intraocular Pressure Therapeutic Profile
PRESS RELEASE published on 02/24/2026 at 07:30, 4 months 4 days ago Nicox Highlights Positive NCX 470 Phase 3 Data Confirming Therapeutic Profile at the 2026 American Glaucoma Society Annual Meeting Nicox announces positive NCX 470 Phase 3 data on intraocular pressure lowering efficacy at 2026 American Glaucoma Society Annual Meeting Nicox NCX 470 Phase 3 Data Intraocular Pressure Glaucoma Society
BRIEF published on 02/16/2026 at 07:35, 4 months 12 days ago Nicox is preparing an NDA submission for NCX 470 following a positive FDA opinion FDA Glaucoma NDA Nicox NCX 470
BRIEF published on 02/16/2026 at 07:35, 4 months 12 days ago Nicox Receives Positive Feedback from FDA for NCX 470 NDA FDA Nicox Glaucoma Treatment NCX 470 NDA Submission
PRESS RELEASE published on 02/16/2026 at 07:30, 4 months 12 days ago Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470 Nicox receives positive feedback from pre-NDA meeting with U.S. FDA for NCX 470, on track for NDA submission in summer 2026. NCX 470 lowers intraocular pressure in glaucoma patients FDA Nicox NCX 470 Intraocular Pressure Pre-NDA
BRIEF published on 02/12/2026 at 07:35, 4 months 16 days ago Nicox maintains its PEA-PME status for 2026 PEA-PME Euronext Growth Paris Investment Ophthalmology Nicox
Published on 07/01/2026 at 01:00, 1 hour 4 minutes ago Onco-Innovations Announces Term Sheet for Notional CAD$5 Million Performance-Based Funding Arrangement and Amendments to Previously Announced Financing
Published on 07/01/2026 at 00:00, 2 hours 4 minutes ago Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010
Published on 06/30/2026 at 23:01, 3 hours 3 minutes ago NextSource Materials Provides Clarification on a Prior News Release
Published on 06/30/2026 at 22:30, 3 hours 34 minutes ago International Battery Metals Announces Change of Auditor
Published on 06/30/2026 at 22:12, 3 hours 52 minutes ago Gold Terra Announces Filing of Technical Report on the Yellowknife Project, NWT and 2026 Annual General and Special Meeting Results
Published on 06/30/2026 at 22:48, 3 hours 15 minutes ago Abivax Announces Launch of Public Offering of American Depositary Shares
Published on 06/30/2026 at 21:53, 4 hours 11 minutes ago EQS-Adhoc: aconnic AG: announces the prolongation of the existing debt facility and postpones the publication of the financial report 2025 on or before September 30th, 2026
Published on 06/30/2026 at 20:43, 5 hours 20 minutes ago EQS-Adhoc: BayWa AG: Understanding in principle on a concept for adjusting the restructuring agreement with key creditors and major shareholders
Published on 06/30/2026 at 20:16, 5 hours 47 minutes ago Finexity AG: FINEXITY publishes final figures for the 2025 financial year
Published on 06/30/2026 at 19:15, 6 hours 49 minutes ago 45 years of OHB: From a five-person operation to a leading European space company
Published on 06/30/2026 at 20:52, 5 hours 11 minutes ago Number of shares and voting rights - May 2026 (In French only)
Published on 06/30/2026 at 18:59, 7 hours 4 minutes ago SUEZ has successfully completed a €600 million green bond issuance
Published on 06/30/2026 at 17:45, 8 hours 19 minutes ago Carrefour completes the sale of Carrefour Romania to Paval Holding
Published on 06/30/2026 at 17:40, 8 hours 24 minutes ago Schneider Electric announces agreement to acquire Cognite, unlocking a new level of strategic intelligence for Industrial AI
Published on 06/30/2026 at 07:30, 18 hours 34 minutes ago Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
